Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Colorectal Neoplasms

  Free Subscription


20.05.2019

1 Ann Surg Oncol
2 Anticancer Res
5 BMC Cancer
4 Dis Colon Rectum
1 Eur J Cancer
1 Eur J Surg Oncol
4 Gastroenterology
1 Gut
1 Int J Colorectal Dis
1 Int J Oncol
1 J Am Coll Surg
1 J Clin Oncol
3 J Surg Oncol
2 Lancet Gastroenterol Hepatol
1 Oncology (Williston Park)
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. FEFERMAN Y, Solomon D, Bhagwandin S, Kim J, et al
    Sites of Recurrence After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Carcinomatosis from Colorectal and Appendiceal Adenocarcinoma: A Tertiary Center Experience.
    Ann Surg Oncol. 2019;26:482-489.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. RADES D, Hansen HC, Janssen S, Schild SE, et al
    Diagnosis-specific WBRT-30-CRC Score for Estimating Survival of Patients Irradiated for Brain Metastases from Colorectal Cancer.
    Anticancer Res. 2019;39:2569-2574.
    PubMed     Text format     Abstract available

  3. OGAWA H, Kaira K, Motegi Y, Yokobori T, et al
    Role of Amino Acid Transporter Expression as a Prognostic Marker in Patients With Surgically Resected Colorectal Cancer.
    Anticancer Res. 2019;39:2535-2543.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. SUN J, Fei F, Zhang M, Li Y, et al
    The role of (m)SEPT9 in screening, diagnosis, and recurrence monitoring of colorectal cancer.
    BMC Cancer. 2019;19:450.
    PubMed     Text format     Abstract available

  5. CHEN Z, Wu G, Ye F, Chen G, et al
    High expression of MMP19 is associated with poor prognosis in patients with colorectal cancer.
    BMC Cancer. 2019;19:448.
    PubMed     Text format     Abstract available

  6. BURM R, Thewes B, Rodwell L, Kievit W, et al
    Long-term efficacy and cost-effectiveness of blended cognitive behavior therapy for high fear of recurrence in breast, prostate and colorectal Cancer survivors: follow-up of the SWORD randomized controlled trial.
    BMC Cancer. 2019;19:462.
    PubMed     Text format     Abstract available

  7. PENNEY ME, Parfrey PS, Savas S, Yilmaz YE, et al
    Correction to: A genome-wide association study identifies single nucleotide polymorphisms associated with time-to-metastasis in colorectal cancer.
    BMC Cancer. 2019;19:437.
    PubMed     Text format     Abstract available

  8. WANG F, He MM, Wang ZX, Li S, et al
    Phase I study of high-dose ascorbic acid with mFOLFOX6 or FOLFIRI in patients with metastatic colorectal cancer or gastric cancer.
    BMC Cancer. 2019;19:460.
    PubMed     Text format     Abstract available


    Dis Colon Rectum

  9. ALAVI K
    Expert Commentary on the Diagnosis and Treatment of Rectal GI Tumors.
    Dis Colon Rectum. 2019;62:540-541.
    PubMed     Text format    

  10. GOTTESMAN L
    A Little Humility, Please.
    Dis Colon Rectum. 2019;62:e22.
    PubMed     Text format    

  11. LEE GC, Ricciardi R
    The Authors Reply.
    Dis Colon Rectum. 2019;62:e22-e23.
    PubMed     Text format    

  12. ABBASS MA, Kalady MF
    Prognostic Factors in Colon Cancer: "The Wisdom to Know the Difference".
    Dis Colon Rectum. 2019;62:647-649.
    PubMed     Text format    


    Eur J Cancer

  13. VAUGHAN-SHAW PG, Zgaga L, Theodoratou E, Blackmur JP, et al
    Whether vitamin D supplementation protects against colorectal cancer risk remains an open question.
    Eur J Cancer. 2019;115:1-3.
    PubMed     Text format    


    Eur J Surg Oncol

  14. VALLANCE AE, Harji D, Fearnhead NS
    Making an IMPACT: A priority setting consultation exercise to improve outcomes in patients with locally advanced, recurrent and metastatic colorectal cancer.
    Eur J Surg Oncol. 2019 May 7. pii: S0748-7983(19)30397.
    PubMed     Text format     Abstract available


    Gastroenterology

  15. FIEVET A, Mouret-Fourme E, Colas C, de Pauw A, et al
    Prevalence of Pathogenic Variants of FAN1 in More Than 5000 Patients Assessed for Genetic Predisposition to Colorectal, Breast, Ovarian, or Other Cancers.
    Gastroenterology. 2019;156:1919-1920.
    PubMed     Text format    

  16. CONNER BR, Hernandez F, Souders B, Landrith T, et al
    RNA Analysis Identifies Pathogenic Duplications in MSH2 in Patients With Lynch Syndrome.
    Gastroenterology. 2019;156:1924-1925.
    PubMed     Text format    

  17. ZHAO S, Wang S, Pan P, Xia T, et al
    Magnitude, Risk Factors, and Factors Associated With Adenoma Miss Rate of Tandem Colonoscopy: A Systematic Review and Meta-analysis.
    Gastroenterology. 2019;156:1661-1674.
    PubMed     Text format     Abstract available

  18. DWYER AJ, Murphy CC, Boland CR, Garcia R, et al
    A summary of the Fight Colorectal Cancer working meeting: exploring risk factors and etiology of sporadic early-age onset colorectal cancer.
    Gastroenterology. 2019 May 13. pii: S0016-5085(19)40882.
    PubMed     Text format    


    Gut

  19. VUIK FE, Nieuwenburg SA, Bardou M, Lansdorp-Vogelaar I, et al
    Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years.
    Gut. 2019 May 16. pii: gutjnl-2018-317592. doi: 10.1136/gutjnl-2018-317592.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  20. WANG X, Mao M, Xu G, Lin F, et al
    The incidence, associated factors, and predictive nomogram for early death in stage IV colorectal cancer.
    Int J Colorectal Dis. 2019 May 15. pii: 10.1007/s00384-019-03306.
    PubMed     Text format     Abstract available


    Int J Oncol

  21. PARK YL, Kim SH, Park SY, Jung MW, et al
    Forkheadbox A1 regulates tumor cell growth and predicts prognosis in colorectal cancer.
    Int J Oncol. 2019;54:2169-2178.
    PubMed     Text format     Abstract available


    J Am Coll Surg

  22. NELSON H, Chia N
    Gut Microbiome and Colon Cancer: A Plausible Explanation for Dietary Contributions to Cancer.
    J Am Coll Surg. 2019 May 10. pii: S1072-7515(19)30310.
    PubMed     Text format    


    J Clin Oncol

  23. SMITH TG, Troeschel AN, Castro KM, Arora NK, et al
    Perceptions of Patients With Breast and Colon Cancer of the Management of Cancer-Related Pain, Fatigue, and Emotional Distress in Community Oncology.
    J Clin Oncol. 2019 May 17:JCO1801579. doi: 10.1200/JCO.18.01579.
    PubMed     Text format     Abstract available


    J Surg Oncol

  24. RAUSA E, Bianco F, Kelly ME, Aiolfi A, et al
    Systemic review and network meta-analysis comparing minimal surgical techniques for rectal cancer: quality of total mesorectum excision, pathological, surgical, and oncological outcomes.
    J Surg Oncol. 2019;119:987-998.
    PubMed     Text format     Abstract available

  25. MESQUITA-NETO JWB, Mouzaihem H, Macedo FIB, Heilbrun LK, et al
    Perioperative and oncological outcomes of abdominoperineal resection in the prone position vs the classic lithotomy position: A systematic review with meta-analysis.
    J Surg Oncol. 2019;119:979-986.
    PubMed     Text format     Abstract available

  26. LEMOINE L, Thijssen E, Carleer R, Geboers K, et al
    Body surface area-based vs concentration-based perioperative intraperitoneal chemotherapy after optimal cytoreductive surgery in colorectal peritoneal surface malignancy treatment: COBOX trial.
    J Surg Oncol. 2019;119:999-1010.
    PubMed     Text format     Abstract available


    Lancet Gastroenterol Hepatol

  27. SCHREYER AG
    Thinking outside the box: a more efficient diagnostic approach in metastatic colorectal cancer.
    Lancet Gastroenterol Hepatol. 2019 May 9. pii: S2468-1253(19)30092.
    PubMed     Text format    

  28. TAYLOR SA, Mallett S, Beare S, Bhatnagar G, et al
    Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trial.
    Lancet Gastroenterol Hepatol. 2019 May 9. pii: S2468-1253(19)30056.
    PubMed     Text format     Abstract available


    Oncology (Williston Park)

  29. SINICROPE FA
    Evaluating Immunotherapy in Nonmetastatic Colorectal Cancer.
    Oncology (Williston Park). 2019;33.
    PubMed     Text format    


    PLoS One

  30. ARRIBA M, Sanchez C, Vivas A, Nutu OA, et al
    Intermediate-onset colorectal cancer: A clinical and familial boundary between both early and late-onset colorectal cancer.
    PLoS One. 2019;14:e0216472.
    PubMed     Text format     Abstract available

  31. K B A, Madhavan A, T R R, Thomas S, et al
    Short chain fatty acids enriched fermentation metabolites of soluble dietary fibre from Musa paradisiaca drives HT29 colon cancer cells to apoptosis.
    PLoS One. 2019;14:e0216604.
    PubMed     Text format     Abstract available

  32. LU S, Catalano C, Huhn S, Pardini B, et al
    Single nucleotide polymorphisms within MUC4 are associated with colorectal cancer survival.
    PLoS One. 2019;14:e0216666.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: